Egetis Therapeutics — Major Shareholding Notification 2022

May 18, 2022

Issuer Egetis Therapeutics AB (publ)

Holder

5568375751

Instrument

Instrument	aktier
Before the transaction
Shares	16,572,442
Voting rights	16,572,442
Transaction
Reason for major shareholding notification New share issue
Date	17/05/2022
Limit for number of shares	10 %
Limit for number of votes	10 %
After the transaction
Quantity
Shares	17,668,330
Directly held voting rights	17,668,330
Indirectly held voting rights	0
Percentage
Directly held shares	8.2 %
Directly held voting rights	8.2 %
Indirectly held voting rights	0 %

Resulting distribution of total holdings

		Percentage of voting rights:	Number of underlying shares:
Shares		8.2 %	17,668,330
	Instruments - FITA Ch. 4, section 2, first paragraph, line 2
	Instruments - FITA Ch. 4, section 2, first paragraph, line 3
	- Physically settled
	- Cash settled
Total		8.2 %	17,668,330
Published
	18/05/2022 11:10
Contact
Name	Kennet Rooth
Phone	+46702741553 Email kennet.rooth@gmail.com

CLOSE PRINT

rapportering@fi.se Tfn 08-408 980 37 Fax 08-24 39 25